GB1062899A - Improvements in and relating to therapeutic compositions - Google Patents

Improvements in and relating to therapeutic compositions

Info

Publication number
GB1062899A
GB1062899A GB266063A GB266063A GB1062899A GB 1062899 A GB1062899 A GB 1062899A GB 266063 A GB266063 A GB 266063A GB 266063 A GB266063 A GB 266063A GB 1062899 A GB1062899 A GB 1062899A
Authority
GB
United Kingdom
Prior art keywords
caffeine
sodium
theophylline
milligrams
strychnine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB266063A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TREVOR EDMUND THOMAS WESTON
Original Assignee
TREVOR EDMUND THOMAS WESTON
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TREVOR EDMUND THOMAS WESTON filed Critical TREVOR EDMUND THOMAS WESTON
Priority to GB266063A priority Critical patent/GB1062899A/en
Publication of GB1062899A publication Critical patent/GB1062899A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A therapeutic composition for increasing human virility and stimulating human emotions comprises (a) any one of nicotinic acid (25 to 150 milligrams) or nicotinamide (10 to 150 mg.), (b) any one of caffeine (100 to 1000 mg.), caffeine citrate (100 to 1000 mg.), caffeine sodium benzoate (100 to 1000 mg.), theophylline with ethylene diamine (50 to 500 mg.), theophylline with sodium acetate (50 to 500 mg.), or theobromine with sodium salicylate (0.5 to 2000 mg.), (c) any one of strychnine sulphate (1 to 10 mg.), strychnine hydrochloride (1 to 10 mg.), extractum nucis vomicae siccum (10 to 100 mg.), Yohimbine (1 to 10 milligrams) or picrotoxin (0.5 to 3 mg.) and (d) an inert diluent. The composition, which may be in tablet or liquid form, may also contain 1 to 50 mg. of manganese and.or sodium hypophosphite, and if desired vitamin constituents.
GB266063A 1963-01-22 1963-01-22 Improvements in and relating to therapeutic compositions Expired GB1062899A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB266063A GB1062899A (en) 1963-01-22 1963-01-22 Improvements in and relating to therapeutic compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB266063A GB1062899A (en) 1963-01-22 1963-01-22 Improvements in and relating to therapeutic compositions

Publications (1)

Publication Number Publication Date
GB1062899A true GB1062899A (en) 1967-03-22

Family

ID=9743516

Family Applications (1)

Application Number Title Priority Date Filing Date
GB266063A Expired GB1062899A (en) 1963-01-22 1963-01-22 Improvements in and relating to therapeutic compositions

Country Status (1)

Country Link
GB (1) GB1062899A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2236674A (en) * 1989-09-20 1991-04-17 Wyeth John & Brother Ltd Pharmaceutical composition containing gaba autoreceptor antagonists

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2236674A (en) * 1989-09-20 1991-04-17 Wyeth John & Brother Ltd Pharmaceutical composition containing gaba autoreceptor antagonists
US5118690A (en) * 1989-09-20 1992-06-02 John Wyeth & Brother Limited Pharmaceutical tetrahydroisoquinolines
GB2236674B (en) * 1989-09-20 1994-05-04 Wyeth John & Brother Ltd Use of gamma amino butyric acid autoreceptor antagonists for the manufacture of medicaments

Similar Documents

Publication Publication Date Title
IL33526A (en) Sulphamyl-benzoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL33500A0 (en) Thiazolyl-benzoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL29778A (en) Pharmaceutical compositions containing picolinic acid,derivatives thereof,and their preparation
IL37164A (en) Barbituric acid derivatives and compositions comprising them
GB1062899A (en) Improvements in and relating to therapeutic compositions
IL38090A (en) Pharmaceutical compositions containing nicotinic acid derivatives
ZA71337B (en) 5-aryl-2,3-dihydro-2,2(or 3,3)dimethyl-5h=imidazo(2,1-a)isoindol-5-ols and 2(4,4(5,5)dimethyl-2-imidazolin-2-yl)bensophenone acid addition salts and processes for their preparation
IL35717A0 (en) Quinoxaline-2-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL35490A (en) 6-amidino-penicillanic acid derivatives,their preparation and pharmaceutical compositions containing them
IL36233A0 (en) Imidazole derivatives,their manufacture and pharmaceutical compositions containing them
IL34086A (en) 1-aryl-1,2,3-triazole-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
NL167970C (en) PROCESS FOR PREPARING NERIIFOLINE DERIVATIVES AND THERAPEUTIC PREPARATIONS CONTAINING SUCH DERIVATIVES AND FORMED THERAPEUTIC PREPARATIONS.
NL163718C (en) PROCESS FOR PREPARING VITAMIN D & 013.
FR1974M (en) Medicinal product based on a complex of vitamin b12 and tannin.
GB1269616A (en) Improvements in pharmaceutical compositions
IL37752A0 (en) Imidazo(4,5-b)pyridine derivatives,processes for their preparation and pharmaceutical and veterinary compositions containing the same
IL35309A0 (en) 2,4-dioxo-1,3-benzoxazinothionophosphonic acid esters,process for their preparation,and their use as insecticides and acaricides
IL36580A0 (en) Ortho-phenylenediamine derivatives,processes for their preparation and fungicidal compositions containing the same
SE386181B (en) PROCEDURE FOR THE PREPARATION OF 6- (D - (-) - 2,2-DIMETHYL-4- (3-CHLORO-4-HYDROXYPHENYL) -5-OXO-1-IMIDAZOLIDINYL) PENICILLANIC ACID AND NON-TOXIC PHARMACEUTICALS ACCEPTABLE.
IL33942A0 (en) Triazole derivatives,their preparation and pharmaceutical compositions containing them
GB1390452A (en) Iron preparation
IL34158A0 (en) Adamantylcarboxamido-phenylacetic acid and its derivatives,their preparation and pharmaceutical compositions containing them
AU1967267A (en) Cinnamic acid derivatives, process forpreparing the same and pharmaceutical compositions compprising the derivatives
FUKUSHIMA My Polysaccharide Therapy of Haman Cancer and the Study on Polysaccharide by Hamashima et al
IL38089A (en) Nicotinic acid derivatives,their manufacture and pharmaceutical compositions containing them